RxDoctor Payments DataLook up a doctor →

Andrea Hayes

Nashville, TNNPI 1992744676

Payments from drug & device makers

$201,120in general payments, 2019–2025

Across 942 payments — averaging $213.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$100K
  • Sanofi-aventis U.S. LLC$18K
  • Esperion Therapeutics, Inc.$17K
  • Tandem Diabetes Care, Inc.$16K
  • Merck$14K
  • Insulet Corporation$11K
  • plus $27K from 30 others

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk154$99,501
Sanofi-aventis U.S. LLC75$18,013
Esperion Therapeutics, Inc.29$16,505
Tandem Diabetes Care, Inc.46$15,919
Merck44$13,527
Insulet Corporation46$10,632
Lilly USA, LLC82$6,789
Valeritas, Inc.20$6,752
Mannkind Corporation139$2,974
Senseonics, Incorporated7$2,900
Medtronic(2 entities)40$1,966
Abbott57$975
Boehringer Ingelheim43$961
Amgen46$961
AstraZeneca(2 entities)26$786
Dexcom, Inc.21$381
Bayer2$244
AbbVie15$220
Johnson & Johnson7$146
Corcept Therapeutics1$140
Lifescan, Inc.6$121
Regeneron Healthcare Solutions, Inc.7$106
Amarin Pharma, Inc.1$106
Radius Health, Inc.6$83
Xeris Pharmaceuticals, Inc.4$74
Zealand Pharma US, Inc.3$66
Companion Medical, Inc.2$51
Shire North American Group Inc3$49
Gilead1$42
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$31
Pfizer2$31
Aytu Biopharma, Inc.1$18
Redhill Biopharma Inc.1$15
Amneal Pharmaceuticals LLC1$13
IBSA Pharma Inc.1$12
Eisai Inc.1$12

Where these figures come from

Is this you, or does something look wrong? →